Welcome to AACR ANNUAL MEETING 2023

The success factors for drug discovery and development programs in oncology are closely linked to deep oncology expertise, a sound data-driven disease hypothesis, an optimized clinical drug candidate, and its in-depth characterization.

At NUVISAN, we know how to establish and implement novel mechanistic cellular assays and in vivo pharmacology models into the lead optimization screening tree through our long-standing experience with different drug targets.

With the help of our biomarker discovery platform, we speed up entry into the clinic by selecting the right patient population.

Contact Us Watch Video